APPLE – 47,5 MILLION iPHONES
APPLE Inc. (NASDAQ:AAPL) reported revenues and earnings per share slightly above the market
The top line reached USD 49,600 mn (vs. USD 49,430 mn).
The bottom line stood at USD 1.84 per share (vs. USD 1.81).
The specific figures for the new product – Apple Watch – were not disclosed, as previously announced by the company.
Star product sales – iPhone – were higher than expected, with the issuance of 47.5 mn units (vs. 47.25 mn), and the gross margin also compares favorably with the projections (39.7% vs. 39 , 5%).
The company estimates sales of USD 49,000 mn – USD 51,000 mn in the current quarter.
In terms of technical analysis, APPLE is in a BULISH LEVEL.
Read more:
Earnings Season – Merck Co.
Merck & Co., Inc. (NYSE:MRK) and Merck Sharp & Dohme (MSD) outside the United States and Canada, is an American pharmaceutical company and one of the largest pharmaceutical companies in the world.
The company was established in 1891 as the United States subsidiary of the German company Merck (founded 1668).
Merck & Co. was confiscated by the US government during World War I and subsequently established as an independent American company.
It is the world’s seventh largest pharmaceutical company by market capitalization and revenue.
In terms of technical analysis, this is a WARNING LEVEL.
We are at the earnings season do not miss the opportunity to trade US Shares with low commissions through ActivTrades – Merck & Co. Inc.
Read more:
http://www.merck.com/investors/
https://www.activtrades.co.uk/index.aspx?page=cfds_commissions
bewayopa 
Recent Comments